NRx’s COVID-19 Vaccine Candidate BriLife Impresses In Phase II

Promising Delta Variant Antibody Levels

 
• By Ayisha Sharma
BriLife Is A Live Vaccine • Source: Alamy

More from COVID-19

More from Scrip